It’s goodbye needles as you can keep the flu away with a nasal spray as the US Food and Drug Administration (FDA) has approved AstraZeneca’s FluMist for home use. It can be self-administered by adults ...

Among the companies with reports and trading updates today are Rightmove, Galliford Try, Oxford Biomedica, AstraZeneca, ...

AstraZeneca's breast cancer drug datopotamab deruxtecan didn't show a statistical significance in overall survival compared with chemotherapy, results showed at a phase three trial.

AstraZeneca said on Monday its experimental precision drug developed with Daiichi Sankyo did not significantly improve ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly ...

Arab Finance: AstraZeneca Egypt is planning to inject $50 million into new investments in Egypt, equivalent to nearly 50% of the company’s capital, the firm’s Country President Hatem Werdany stated.

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.

The FDA approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.

The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...

Recent health news highlights key regulatory approvals and legal actions. The EU backs Novo Nordisk's Wegovy for an ...

The HBCU Week Foundation, a non-profit organization dedicated to supporting Historically Black Colleges and Universities ...